NAM-powered HIV research lab expansion at UL Lafayette
Official title: Supplemental NAM Equipment-Funding Request to C06 Award No. 1C06OD034041
Funded at University of Louisiana at Lafayette · NIH-11581662 · Data updated 2026-11-12
A small grant will fund a modernized lab space and new methods to study HIV using human-relevant models and AI-enabled analysis.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | September 18, 2026 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $30,246 |
| NIH project number | 3C06OD034041-01S2 |
| Project ID | NIH-11581662 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV or at risk for HIV who could benefit from better therapies informed by NAM-based research.
✕Less likely to help
The grant funds infrastructure and basic research; no immediate patient treatments are delivered by this grant.
What this research studies
This grant supports renovating a lab space at the New Iberia Research Center to host up to six multidisciplinary teams. Researchers will use next-generation human-relevant in vitro systems, organoids, microphysiological models, multi-omics, and AI analytics to study HIV pathogenesis and treatment. The goal is to advance new approaches that could lead to durable viral remission and better therapies for people living with HIV. The project emphasizes modern infrastructure to enable collaborative, cutting-edge HIV research at UL Lafayette.
Why it matters
Potential benefit: If successful, the work could accelerate HIV therapy development and improve understanding of viral persistence using advanced human-based models.
How similar studies have gone: Similar NAM-based HIV studies have shown promise in modeling disease and guiding therapeutic discovery, though the field is evolving.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: O'shea, Brian — University of Louisiana at Lafayette
- Study coordinator: O'shea, Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.